Top compounds associated with response to RP11-216L13.17


Feature Type Standardized
Nominal ANOVA
mRNA SGX-523 CTRPv2 pan-cancer AAC 0.12 0.005
mRNA pluripotin CTRPv2 pan-cancer AAC -0.11 0.005
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.092 0.005
mRNA PHA-793887 CTRPv2 pan-cancer AAC -0.096 0.005
mRNA lovastatin CTRPv2 pan-cancer AAC -0.11 0.006
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.1 0.006
mRNA PI-103 CTRPv2 pan-cancer AAC -0.11 0.006
mRNA BCL-LZH-4 CTRPv2 pan-cancer AAC 0.16 0.006
mRNA Teniposide CTRPv2 pan-cancer AAC -0.12 0.007
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.1 0.007
Download CSV